课题基金 / 基金详情

High Efficiency Dialyzer Development

High Efficiency Dialyzer Development
高效透析器开发
批准号:
6402952
负责人:
PHILIP LITWAK
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2002-07-31

项目摘要

项目成果

PHILIP LITWAK的其他基金

相关文献

中文摘要
翻译
该项目的目标是开发一种高效的主动混合
英文摘要
The goal of this project is develop a highly efficient active mixing hemodialyzer for patients in renal failure. We intend to replicate our active mixing membrane oxygenator (AMMO) technology currently under development to this device. Mass transfer in AMMO devices has proven to be 5-8 times more efficient than currently available static oxygenators, while not causing more blood damage than these clinical devices. In addition, the rotational movement of AMMO has resulted in it being a very efficient pump, thereby incorporating two basic functions in a single device. Active mixing functions to increase efficiency by imparting interstitial convection within the hollow fiber array and reducing blood phase resistance, resulting in increased mass transfer efficiency. In other words, motion of the fiber bundle disrupts the concentration boundry layer that impedes mass transfer across the membrane. This Phase I program is designed to evaluate the feasibility of our design. Specifically, using fabrication techniques developed for AMMO we will fabricate multiple active mixing dialyzer prototype variations with appropriate dialysis microporous fibers and dialysate fluid pathways. These units will then be evaluated in vitro per AAMI standards. Based on clearance data obtained we will select the most efficient dialyzer and fabricate a set of identical units for further functional evaluation. Finally, three ex-vivo animal trials to assess basic biocompatibility of the active mixing dialyzer are proposed. PROPOSED COMMERCIAL APPLICATION: Hemodialysis is required by over 200,000 Americans. The active mixing hemodialyzer has the potential to provide for more efficient, hence less time-consuming and lower biomaterials exposure, hemodialysis treatments. In addition, this device will pump blood thereby eliminating another element of current systems. It will be integratable into today's dialysis machines thereby eliminating the need for costly capital expenditures.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Genome-wide detection of a TFIID localization element from an initial human disease mutation.
从初始人类疾病突变中对TFIID定位元件的全基因组检测。
DOI: 10.1093/nar/gkq1035
发表时间: 2011-03
期刊: Nucleic acids research
影响因子: 14.9
作者: [Yang MQ, Laflamme K, Gotea V, Joiner CH, Seidel NE, Wong C, Petrykowska HM, Lichtenberg J, Lee S, Welch L, Gallagher PG, Bodine DM, Elnitski L]
通讯作者: Elnitski L
Ambulatory ECMO System
  • 批准号:
    6484355
  • 项目类别:
  • 资助金额:
    $19.98万
  • 财政年份:
    2002
  • 负责人:
    PHILIP LITWAK
  • 依托单位:
Simplified Pump Oxygenator for Pediatric Use Phase II
  • 批准号:
    6550618
  • 项目类别:
  • 资助金额:
    $68.17万
  • 财政年份:
    2001
  • 负责人:
    PHILIP LITWAK
  • 依托单位:
Simplified Pump Oxygenator for Pediatric Use
  • 批准号:
    6337531
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2001
  • 负责人:
    PHILIP LITWAK
  • 依托单位:
Active Mixing Membrane Oxygenator Phase II
  • 批准号:
    6444256
  • 项目类别:
  • 资助金额:
    $35.38万
  • 财政年份:
    1998
  • 负责人:
    PHILIP LITWAK
  • 依托单位: